Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Irinotecan Induced Diarrhea by Probiotics. A Phase III Study

NCT01410955 is registered in ClinicalTrials.gov with Monsea Ltd. as lead sponsor.

NCT NCT01410955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01410955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Irinotecan Induced Diarrhea by Probiotics. A Phase III Study
Lead sponsor
Monsea Ltd.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2014
Enrollment
46 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer